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Abstract: Sickle Cell Disease (SCD), an inherited Red Blood Cell (RBC) 
disorder, is characterized by anaemia, end-organ damage, unpredictable 
episodes of pain and early mortality. SCD affects 25% of people living in 
Central and West Africa causing life threatening “silent” strokes and 
lifelong damage. Nigeria accounts for 50% of SCD births worldwide 
(estimated 150,000 of 300,000 babies born with Symptomatic Sickle Cell 
Anaemia (SSCA) yearly, an annual infant death of 100,000 (8% of her 
infant mortality)) and about 2.3% of her population suffers from SCD with 
40 million (25%) being healthy carriers. The number of such babies born 
with SSCA yearly has been estimated as 400,000 by year 2050. Healthcare 
resources for SCD are inadequate and the numbers of SCD are increasing 
daily, thereby demanding more sufficient resources. Intermittent and 
recurrent acute pain episodes are associated with SCD as a result of vaso-
occlusion. Pain management at the Emergency Department for vaso-
occulsive crisis for patients with SCD has been obnoxious. Biopsychosocial 
assessment and multidisciplinary pain management may be required when 
treating patients with frequent, painful sickle cell crises. Early and 
aggressive SCD-related pain management becomes a priority to improve 
quality of life and prevent worsening morbidities. Computational 
Intelligence-based framework in promoting higher-quality care and 
consequent increased life-expectancy in SCD patients is expedient. Monte 
Carlo Simulation Technique of Random Number Generation was used to 
generate 515 datasets for enhanced fifteen attributes of SCD. The 
datasets’ features of SCD were used to train the neural network according 
to the pain encountered in identifying and treating the patient as fast as 
possible. This paper provides back-propagation algorithm of Artificial 
Neural Network in optimizing SCD-related pain classification and 
treatment processes, to complementa multidisciplinary care team 
intervention thereby increasing the quality of life. 
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Introduction 
Siddique and Adeli (2013) stated that computational 
Intelligence (CI) promised to advance the healthcare 
sector and clinical practice of disease management in 
diagnosis, treatment, prevention, prescription and 
optimization of the fast delivery to patient with these 
diseases. Akinwonmi (2011) confirmed Artificial Neural 
Network (ANN)’s connection/strength could be 
determined by the activation function which could be 
either linear or non-linear. Further, ANN consists of 
three layers (the input layer, output layer and hidden 
layer which is between the previous two layers.ANN’s 
learning capabilities (supervised, unsupervised and 
reinforcement) are techniques used in learning. By 
adjusting the weight, the neural network adapts itself to 
learn and optimise to produce the desired output. Liu et al. 
(2006) affirmed ANN has been used in healthcare sector 
by applying the classification methods as ANNs 
identify the dataset features in order to accurately 




diagnose the nature of diseases, pains and sicknesses. 
According to Macintyre et al. (2010), Sickle Cell 
Disease (SCD), a systemic multiorgan disease that most 
commonly presents with painful vaso-occlusive crises, 
occurs either spontaneously or due to factors such as 
dehydration, infection, hypothermia and low oxygen 
tension. Jain and Gupta 2016); Xu et al., 2017) 
discovered that SCD, a hematological disorder, leads to 
blood vessel occlusion accompanied by painful episodes 
and even death. The three basic factors/blood 
components (RBC, MCH and Hb) that are affected in 
Symptomatic Sickle Cell Anaemia (SSCA) are: (1) 
Mean Corpuscular Haemoglobin (MCH), the average 
amount of haemoglobin found in red blood cells and 
measured in pictograms; (2) Red Blood Cells (RBCs), 
which carry oxygen. Normal RBC range in Males is 4.7 
to 6.1 million cells per micro liter (cells/mcl) and in 
females is 4.2 to 5.4 million cells/mcl. People suffering 
from SSCA have RBC in the range 2.37-3.73 cells/mcl. 
RBCs of SCD patients have diverse shapes that reveal 
important biomechanical and bio-rheological 
characteristics, e.g., their density, fragility, adhesive 
properties, etc and (3) Hemoglobin (Hb or Hgb), the iron-
containing oxygen-transport metalloprotein in the RBCs, 
is measured in g/dl. A short summary of the variation in 
the values of these factors is given in Table 1. 
SCD becomes one of the most common severe life-
threatening haematological and monogenic disorders 
affecting millions of people worldwide. Affected 
blood is less able to carry oxygen and flow smoothly, 
which causes a host of health problems and a shorter 
lifespan. Piel et al. (2013; Kristiansen, 2014) reported 
that SCD occurs in people of African, Arabic and 
Indian  racial  backgrounds while countries in 
Equatorial      Africa     bear    the    greatest     burden. 
 
Table 1: Normal andanaemicrange of RBC, MCH and Hb 
(Jain and Gupta, 2016) 
Blood components Normal range Anaemic range 
RBC(cells/mcl) 4.2-6.1 2.37-3.73 
MCH (pg) 25.63-29.23 26.52-32.16 
Hb (g/dl) 25.63-29.23 6.63-10.87 
 
Table 2:  Burden of sickle cell disease (Kristiansen, 2014)  
Country Sickle cell births/year 
Nigeria 91,011 









Sub-Saharan Africa Total 242,187 
Worldwide Total 305,773 
It was further stated that three-quarters of children who 
inherit SCD are born in sub-Saharan Africa, but most 
have no access to treatment and die before their fifth 
birthday. As shown in Table 2, worldwide, over 
300,000 babies are born with SSCA yearly having 
sickle hemoglobin gene and this figure may increase to 
400,000 by the year 2050. 
The usual disorder in an individual is SCD.    Rees et al. 
(2010; Akinsete and Osu, 2017) have reported that 43 
million people have sickle-cell traits and 4.4 million people 
have SCDs. Akinsete and Osu (2017) also estimated that 40 
million Nigerians are carriers of this disease with over 
150,000 infants born with SSCA. This situation translates to 
Nigeria having the highest record of SCD, where infant’s 
death of this carrier is estimated to be 100,000 in Nigeria 
representing eight percent of her mortality rate. 
Case et al. (2018) submitted that SCD’s management 
would social and cultural sensitivity of the practitioner’s 
expert and experience due to the patient’s challenging 
condition. Pain is a major issue in the care of patients 
with SCD. Dampier et al. (2014) found out that 
mechanisms behind pain and the best way to treat it have 
not been well understood. Vaso-Occlusive Crises (VOC) 
constitute SCD’s painful episodes. Acute and chronic 
pains are mostly associated with adult patients, while 
acute pain is common in infants and children to classify 
the pain based on recent findings. On their own part, 
Macintyre et al. (2010) recommended that 
biopsychosocial assessment and multidisciplinary pain 
management might be required when treating patients 
with frequent, painful sickle cell crises. Telfer et al. 
(2014) concluded that SCD’s acute painful crisis 
management remained unsatisfactory despite advances in 
the understanding and management of acute pain in other 
clinical settings. In corroborating, Lanzkron and Carlton 
(2015) discovered that the lack of a strong evidence base 
to guide the management/treatment of SCD-associated 
acute pain episodes have made it difficult for patients to 
receive high quality care outside of specialty centers. 
According to Poku et al. (2018) and Ginter et al. (2018), 
most hospitals and healthcare practitioners are using 
the traditional manual approach for management of 
patients with SCD, which can be time consuming and 
stressful to both patients and practitioners. Lanig et al. 
(2018) affirmed the daily increase in SCD would require 
more sufficient resources, such as healthcare 
professionals and practitioners, which are said to be 
inadequate. These inadequate healthcare workforce 
resources for SCD also often lack the required clinical 
experience while those working in the rural areas often 
lack the knowledge for clinical practice. Devi et al. (2013; 
Reader et al., 2017) reported ANN has been applied to 
SCsD for diagnosis, prediction and classification but has 
not been applied for the management of pain in SCDs. 




Treatment of Sickle Cell Disease 
Artificial Neural Network Optimization 
Jin et al. (2005) reported different researchers have 
compared various techniques such as Back-propagation, 
Simulated Annealing, ANN and Genetic Algorithm 
(GA) for optimizing processes in a network. While 
Simulated Annealing and GA have been proved to be 
global search techniques for optimization, Back-
propagation algorithm is the mostly used for 
optimization techniques for training the neural network 
to find optimal solutions. While datasets are fed into the 
network through the input layer, the weight in the 
network is updated, by adjusting in an attempt to 
optimize the process and minimize the loss function, Sun 
et al. (2003) observed that best solutions are obtained in 
the area of the point which is more effective and 
consistent. In adjusting the weight, Agatonovic and 
Beresford (2000) had earlier stated that the 
interconnections of the nodes are strengthened while 
some are dropped (weakened) so that the neural network 
can output a better solution. Finally, the network training 
comes to halt when the best and optimal solution is 
obtained. Ibrić et al. (2012) opined that datasets’ features 
could be classified into training and test datasets at a start 
of the training. Furthermore, the predictive uses test data 
while the training data is used to obtain optimal solution 
which changes the error, while the evaluation of the data 
is done by using both training and test data. The latter is 
done simultaneously. Table 3 shows the steps to follow in 
supervised training of network and usage. 
Pain in Sickle Cell Disease 
Macintyre et al. (2010) proposed that uncontrolled or 
unexpected pain would require a reassessment of the 
diagnosis and consideration of alternative causes for the 
pain (e.g., new surgical/medical diagnosis, neuropathic 
pain). Equally important is the fact that multiple 
outcome measures are required to adequately capture the 
complexity of the pain experience and how it may be 
modified by pain management interventions. Pain 
management in SCD is challenging due to both the 
frequent crisis being faced by the patient and the 
inability of the healthcare practitioner to quickly identify 
the pain as the RBC disorder constitutes the cause of the 
painful complication in SCD as ascertained by Case et 
al. (2017). Ballas (2005) had earlier classified pains in 
SCD as chronic pain, acute pain, neuropathic pain or 
mixed pain. These are unpredictable and can occur at 
any time. Chronic pain is the outcome of the frequent 
acute pain that has not been properly taken care of. The 
pain can be experienced between three months and more.  
Table 3: Optimization of the ANN in solid dosage form 
(Ibrić et al., 2012) 
Training of the network 
Data is presented to the network 
Network computes an output 
Network output is compared to desired output 
Network weights are modified to reduce error 
Usage of the network 
Present new, unseen data to the network 
Network computes an output based on its training 
 
Some of the symptoms are achy, frequent in nature and 
this happens in a pathophysiologic events. Acute pain 
can occur throughout the life of the SSCA patient. The 
pain can be so sudden leading to Vaso-Occlusion (VOC) 
crisis and can cause damage to the organ which can 
sometimes lead to death if not properly managed. 
Neuropathic pain occurs as a result of wound or 
dysfunction in the body and is associated with SCD 
which can be triggered by harmful or deadly things. 
Dampier et al. (2017) corroborated Ballas (2005)’s 
classification and expressed that SCD-related pain is 
associated with increased morbidity, mortality and high 
health care costs. Dampier et al (2017), in giving a 
common set of criteria for classifying chronic pain 
associated with SCD, concluded such classification 
would enhance SCD pain research efforts in 
epidemiology, pain mechanisms and clinical trials of 
pain management interventions and ultimately improve 
clinical assessment and management by adopting a 
Proforma for Pain Assessmentas given in Fig. 1 (Howard 
and Telfer, 2015).  
Due to the challenges in identifying and treating the 
painful episodes of the SCD which occur from offspring 
and can continue throughout the lifespan of that patient, 
frequent pain of acute nature requires quality healthcare 
and attention by the practitioners. Macintyre et al. (2010; 
Case et al., 2017; Howard and Telfer, 2015) 
recommended that the Acute Painful Crisis (APC), an 
episode of pain, usually of abrupt onset, in severe cases 
would require hospital treatment with opioid analgesia. 
While parenteral corticosteroids appear to reduce the 
duration of analgesia requirements and length of hospital 
stay, without major side effects, during sickle cell crises, 
one of the most important complications of APC is 
Acute Chest Crisis (ACS). In their submissions, 
Macintyre et al. (2010), Howard and Telfer (2015) and 
Case et al. (2017) identified monitoring for development 
of ACS with regular assessment of respiratory rate, oxygen 
saturation and daily examination of the chest as an essential 
part of the management of APC. There is insufficient 
evidence to suggest that fluid replacement therapy reduces 
SCD- associated pain. Hydroxyurea is effective in 
decreasing the frequency of acute crises, life-threatening 
complications and transfusion requirements in SCD. 




The Sickling Phases 
Hemoglobin has a rope-like structure - the sickle - 
which is a trait in SSCA. Molecules of the hemoglobin 
are put together to form fibres and then aggregated into 
twisted pairs. US_NIH (2014) affirmed SSCA-
hemoglobin consists of four sickling phases: HbS, 
P+chain, deoxy+bs and polymer while each of the 
hemoglobin molecules is called heme group. 
Haemoglobin polymerisation leads to abnormal sickle-
shaped erythrocytes’ rigidity to disrupt blood flow in 
small vessels. Figure 2 shows the sickling phases 
(Howard and Telfer, 2015). 
The most prevalent SCD genotypes associated with 
the most severe clinical manifestations include 
homozygous hemoglobin SS (HbSS) and the compound 
heterozygous conditions hemoglobin Sβ0-thalassemia 
(HbSβ0-thalassemia), hemoglobin Sβ+-thalassemia 
(HbS β +-thalassemia) and hemoglobin SC disease 
(HbSC). Vaso-occlusion (central to the pathophysiology 
SCD) leads to distal tissue ischaemia and inflammation, 
with symptoms defining the acute painful sickle-cell 
crisis. The importance of chronic anaemia, haemolysis 
and vasculopathy has been established. Nevertheless, 
repeated sickling and ongoing haemolyticanaemia, even 
when subclinical, lead to parenchymal injury and chronic 
organ damage, causing substantial morbidity and early 
mortality. Consequences of sickling include destruction 
to the membrane and cytoskeleton, removal in the RBC, 
red cell dehydration and impaired anti-oxidant 
mechanisms. Figure 3 shows the sickle cell crisis which 




Fig. 1: Proforma for pain assessment (Howard and Telfer, 2015) 
Patients name: 
 




Pain and Analgesia Assessment 
Date/Time 
Site of pain: Duration of pain: 
































Analgesia taken in the last 8 hrs: 
Patients with ANY of the below should be referred for medical review 
Chest Pain, Shortness of breath, Hypoxia (oxygen saturation <94% 
Fever/rigors (Temp>38°C). Hypertension (BP <90/60) 
 
Tachycardia>1100 (even after pain has settled following analgesia) 
Raised respiratory rate of >20(even after pain has settled following analgesia) 
New neurological symptoms, headache, confusion, numbness of limbs 
Abdominal pains 
 
Priapism (persistent erection) 
 
Pregnancy 
Visual loss or bleeding in the eye 
PAR>four 
Concerns from the nursing learn about the patients’ clinical condition. 











Fig. 3: Picturing sickle cell crisis (Creason, 2010) 
 
Howard and Telfer (2015) certified opioid drugs 
are potentially toxic and inappropriate dosing could 
result in excess morbidity and mortality, particularly 
from respiratory suppression and excessive sedation. 
Consequently, Dampier et al. (2017) recommended 
frequent monitoring of vital observations including 
respiratory rate and sedation score be made 
mandatory, using Pain Assessment Scale of Fig. 4 
(Howard and Telfer, 2015). 
Vaso-Occlusive Crisis 
Lanzkron et al. (2010) reported SCD causes 
intermittent and recurrent acute pain episodes, referred to 
as ‘Vaso-Occlusive Crises’ (VOC), as a result of vaso-
occlusion. Furthermore, most adults and infants 
experienced these painful episodes (being the most 
common with people having SSCA). VOC occurs when 
there is coagulation of the RBC and this can lead to 
severe injuries or damage to the organ of the body which 
is the most common in the complication. The SSCA’s 
severe complication is responsible for Emergency 
Department (ED) and healthcare sector for SCD patient 
to receive quick treatment with high quality and outmost 
care to save life. Hereditary genetic disorder, also found 
in SCD, results in the predominant production of an 
abnormal/mutant hemoglobin called Hemoglobin S (Hb 
S) in RBCs. Persons carrying one normal hemoglobin 
gene and the S gene are known as having sickle trait 
(AS) and are usually healthy and haematologically 
normal. Sickle shaped red cells, formed when 
hemoglobin offloads oxygen to the tissues, are more 
rapidly removed from the circulation by the body (a 
process called hemolysis) leaving much less 
hemoglobin circulating (anaemia). Complication 
occurrences can lead to VOC. Every SCD patient 
experiences this VOC during his/her life span and if 
the person is not being taken care of during the time of 









2 deoxy-HbS  
Picturing sickle cell crisis 
The sickle (crescent-shaped) blood cells indicate sickle cell anemia. Sickle cell crisis 
causes obstruction of blood flow and pain 




Sickle cell anemia 
Sickle cell crisis Obstruction of 
blood flow 
polymer 






Fig. 4: Pain assessment scale (Howard and Telfer, 2015) 
 
Materials and Methods 
ANN’s ability to learn can be used to implement the 
algorithm capable of learning and optimizing processes 
involved in the management of pain in SCD patient. 
Data are collected by hospitals and healthcare centers 
having records of the entire SCD patients that have been 
diagnosed and treated. With this data we can determine a 
patient that has greater risk by processing and analysing 
the data collected. Neural Network can help to process 
and analyze patients with sickle cell and those that need 
immediate attention. The use of ANN can help predict 
the best practice in management of pain during crisis 
based on the symptoms. Elsalamony (2016) presented 
an algorithm to identify healthy and unhealthy sickle 
cell patient using ANN as structured in Fig. 5. This was 
a neural network which has input layer, output layer 
and hidden layer (between input and output layers), but 
not trained to optimize the processes in the management of 





















Pain  0       1       2      3       4      5        6       7        8        9      10 
0       1       2      3      4       5       6       7        8         9      10 






Pain score pre analgesia 
Mood score pre analgesia 
Sedation score pre analgesia 
Pain score post analgesia 
Mood score post analgesia 
Sedation score post analgesia 
Frequency of observation (to assess oxygen saturations on AIR please remove oxygen for 5 minutes) 
Pain score 0, 1-3 
(No pain-Mild pain) 
O2 sats on air >95% 
Sedation 0/1 
Resp Rate 12-24 
 
4 hourly observations 
Pain score 4 to 6 
(Moderate pain) 
O2 sats on air >95% 
Sedation 2 
Resp Rate 12-24 
 
2 to 4 hourly observations 
Pain score 7 to 10 
(Severe to excruciating) 
O2 sats on air >95% 
Sedation 3 or above 
Resp rate <12 
30 minutes to 2 hourly 
observations 
Respiration 
If an observation or assessment is not undertaken this should be indicates with a clear line 
and the reasons documented in the medical makes and the sickle cell team informed.  
Observation respiration for one minute when patient is rest  
Respiratory rate 
<12/min  
Stop opiates, give oxygen call doctor, 






Ready for discharge 
May be discharged. Give oral paracetamol, NSAID’ s or DF118 (if no contra-indications) to take away. 
Re-evaluate. Give regular or Prn oral analgesia (Paracetamol, NSAID’ s, DF118) if no contra-indications. 
Consider PRN oromorph or low dose subcut morphine if necessary. 
Regular strong opiates analgesia. Refer to register or care plan for individual guidance if available. If dose not settle 
with prescribed analgesia needs review by sickle learn (or medical team out of hours) 
Ask the patient to self-assess, 0 represents an absence of depression/anxiety/stress and 10 represents a very high level of 
depression/anxiety/stress. 
If record score is consistency>7 over 48 hour, refer to health psychology learn. 
More score 
Sedation score-Sedation can precede respiratory depression 
0 normal sloep 
1 alert not sedated 
2 drowsy, slightly sedated 
3 frequently drowsy, moderately sedated 
 
4 difficult to rouse, heavily sedated 
To exclude opiate induced unconsciousness the patient must be gently roused when 
aslope 4 hourly observation. 
Acceptance. 2 hourly observation. Not to leave ward unsupervised 
May require treatment adjustments. Need medical review. 30 minutes to 2 hourly 
observations. Not to leave ward unsupervised 








Table 4: Related works in neural network based approach to sickle cell disease-related pain management 
 Methods/ 
Author Techniques Research Focus Limitation 
Xu et al. (2017) Convolutional  The paper focused on the modeling of No focus on pain management of the Sickle 
 neural network deep convolutional networks in cell diseases-related and the number of datasets 
  classification of different structure used were small in classifying the SCD. 
  of the red blood cell compared with 
  method of independent structure. Both 
  methods gave a good prediction and 
  could assist in the pain of SCD patients. 
Hirimutugoda and Artificial Neural The paper gave an idea of the possible Unable to manage pain in sickle cell anaemia 
Wijayarathna Network (ANN) accurate and faster diagnosis method when a patient is being faced with crisis. 
(2010)  of disorder in red blood cell (RBC) 
McCartney et al. ANN Develop a secure web-based system for The research did not focus on Sickle cell 
(2014)  facial pain diagnosis and evaluate the Diseases in recognizing and optimizing pain. 
  performance having higher accuracy. 
Pombo et al. ICT Technologies The paper reviewed the application of No techniques to learn and optimize the 
(2014)  computer information and technologies processes in management of pain. 
  for pain management using an automated 
  database. 
Tomari et al. Automated system  Classification of RBC with the assistance The automated system was used to train the network 
(2014) and ANN identify of computer system to detect in classifying the RBC into normal/abnormal 
  and Normal and Abnormal RBC by but not for management of pain of the SCD. 
  using ANN classifier. Few datasets were used to classify using ANN. 
Horn et al. Cella Vision system This paper focussed on detecting RBC by No technique was used to optimize or train 
(2015) and ANN microscopy manual differential to theCella network for RBC morphologic abnormalities 
  Vision and comparing performance with ANN. 
Schneider et al. Optical ANN ANN used for classification of the blood cell ANN was not used to train the network but  
(2015)  for cell imaging. Proposed a label-free rather to classify using numerical simulations. 
  technique that uses a discrete numeric  
  holographic microscopy 
Argüello et al. Computational The research recommended computational  No specific model was used; only suggested 
(2015) model technique model techniques for pain management and a computational model for pain management 
  to predict for other healthcare areas. 
Coleman et al. Phenomenological The paper focused on the challenges of the No Computational Technique was used in 
(2016) Analysis painful episodes in SCD, quality of life   optimizing painful sickling episodes. 
  and timing of their experiences 
Tyagi et al. ANN ANN technique was used to classify the Optimizing and prediction of the pain in SCD 
(2016)  normal and abnormal RBC based on the were not considered. 
  datasets features. 
Durant et al. Convolutional The research showed that Convolutional Morphologic profile of blood cells relies  
(2017) Neural Networks NN could be used to indicate White Blood heavily on manual smear processing 
  Count (WBC) with higher accuracy and techniques and visual inspection  
  optimize performance in a clinical and health 
  care sector. 
Khalaf et al. Machine learning ANN was used for classification of medical No training of datasets. It only provided 
(2017) Methods/ANN data for prevention and guidelines for  manual approaches to sickle cell therapy. 
  diseases in Sickle Cell. 
Rahmat et al. Self-Organizing Map The paper classified normal and abnormal System developed could not optimize the 
(2018) Neural Network. RBC of the sickle cell diseases in digital process of pain management in SCD 
   image using self-organizing map neural network. 
 
From Table 4, various researchers acknowledged the fact 
that there is a demonstrated need for management of pain 
in SCD. Equally and importantly accepted is the need to 
optimize the processes of the pain management for better 
healthcare services. 
Training Data for Sickle Cell Disease 
Currently, there is no standardization for pain 
management in SCD. This paper attempts to develop a 
neural network model capable of promoting higher-
quality care by optimizing the processes in managing 
sickle cell patients during pain-induced crisis. This will 
help to improve the quality of life of the patient with 
attendant reduction of unnecessary spending, patient 
illness and pressure for the healthcare practitioners in 
terms of emergency cases they need to attend to per 
time. The SCD attributes adapted from Khalaf et al. 
(2016) in Table 4 were enhanced for consideration with 
Age, Educational Background and Location items. 
Monte Carlo Random Number Generation technique 
has been used in this research to generate dataset using 
the fifteen attributes of Table 5. This approach 
developed a scientific framework that facilitates 
hypothetical generation of a big dataset without necessarily 
going through the time-consuming Ethical Approval 
Committee process of Institutional Review Board. 




Table 5:  Sickle cell Disease Datasets attributes as enhanced from Khalaf et al. (2016) 
S/N Attributes Meaning 
1. Age Length of time that the patient has lived 
2. Weight A body relative mass of that patient 
3. Educational Background Highest educational background of the  
  patient to know the level of literacy 
4. Haemoglobin  The protein found in the Red Blood Cell (RBC) 
  that carries oxygen to every part of the body. 
5. Location  Geographical area and address where the patient lives. 
6. Mean corpuscular volume (MCV) The measure of the size of the red blood cells 
  in the body of the patient. 
7. Platelets (PLTS) Thrombocytes: refer to components of blood  
  whose function is to stop bleeding. 
8. Neutrophils (WBC NEUT) Neutrophils helps to fight infections 
9. Neutrophils count (RETIC A) Real number of White Blood Cells (WBC) present in the patient. 
10. Reticulocyte count (RETIC %) Measures the rate at which reticulocytes are made in the bone 
  marrow and enter the bloodstream. 
11. Alanine Aminotransferase (ALT) test  The blood test that checks for liver damage. It’s an enzyme  
  mostly in liver and kidney cells 
12. Body Bio Blood (BIO) BodyBio wellness Report is a revolutionary report that lets you  
  get the most from the companion blood test. 
13. Fetal Hemoglobin (HbF) The RBC that carries oxygen round the body. 
14. Bilirubin Helps to find the cause of health conditions, like jaundice, liver 
  disease and anaemia. 
15. Lactate Dehydrogenase (LDH) An enzyme involved in the energy production that is found 








Fig. 6: ANN framework for SCD-Related Pain Management; adapted from Karan et al. (2012) 
Sickle Cell Detection 











































Figure 6 presents the neural network to manage the 
pain in sickle cell patient to be able to determine 
between normal and abnormal patient in the processes, 
using the attributes in Table 5.  
About 515 datasets were generated using Monte 
Carlo a Simulation Techniques to Generate Random 
Number for items in Table 5. 
Results 
For the purpose of the work we classified pain into 
four: low acute pain, severe acute pain, low chronic pain 
and severe chronic pain (crisis). Our target output 
percentages are as presented in Table 6. 
Our results using Figs. 6 and 7 are presented in Table 7. 
To validate the system, we have a training dataset and 
testing dataset on classifier model. The evaluation of the 
neural network was based on some certain parameters 
such as sensitivity, specificity, precision, the F1 score, 
Youden’s J statistic and the classification accuracy. Table 
8 shows the formula to evaluate the performance. 
Where TP, TN, FP and FN stand for true positive, 
true negative, false positive and false negative 
respectively for the evaluation performance. Back-
propagation method was used for training the datasets. 
The activation function was determined by the weight of 
the network, the gradient of the loss function fed into the 
network to the back-propagation to update the weights of 
the function in order to reduce the loss function. This 
was done using a supervised form of learning in ANN. 
The ANN could learn from the datasets and be able to 
recommend the best processes in management of pain of 




Fig. 7: Sample of data generated 
 
Table 6: Target output percentage 
Pain classification Percentage classification Class number 
Less acute pain 0-25% 1 
Severe acute pain 26-50% 2 
Less chronic pain 51-75% 3 
Severe chronic pain 76-100% 4 
 
Table 7: Attributes classification 
 Attributes classification 0-25% 26-50% 51-75% 76-100% 
S/N Class number 1 2 3 4 
1 Age 0-25 years 26-50 years 51-75 years 76-100 years 
2 Weight  Under Weight  Normal Weight Over Weight Obesity 
3 Educational Background Illiterate  High School Graduate Post Graduate 
4 Haemoglobin Low Normal High Very High 
5 Location Rural Urban Sub-urban Exurban 
6 Mean corpuscular Volume(MCV) Low Normal High Very High 
7 Platelets (PLTS) Low Normal High Very High 
8 Neutrophils (WBC) Low Normal High Very High 
9 Neutrophils Count Low Normal High Very High 
10 Reticulocyte Count Low Normal High Very High 
11 Alamine Aminotransferase (ALT Test) Low Normal High Very High 
12 Body Bio Blood Low Normal High Very High 
13 Fetal Haemoglobin Low Normal High Very High 
14 Bilirubin Low Normal High Very High 
15 Bilirubin dehydrogenase Low Normal High Very High 




Table 8: Performance metric calculation, adapted from (Karayiannis and Venetsanopoulos, 2013) 




F1 Score 2 * (Precision * Recall)/(Precision + Recall) 
Youden’s J statistic (J Score) Sensitivity + Specificity – 1 
Accuracy (TP + TN)/(TP + FN + TN + FP) 
Area under ROC 0  Area under the 
Curve (AUC) ROC curve  1 
 
Discussion 
Back-Propagation Neural Network (Multilayer 
Perceptron) with supervised learning model has been 
applied in SCD pain management processes in 
promoting higher-quality care. The datasets features of 
the SCD patients were used to train the neural network 
according to the pain encountered in identifying and 
treating the patient as fast as possible. Performance 
evaluation metric of the training datasets would help 
determine the accuracy and effectiveness of the Neural 
Network for utmost result. 
Conclusion 
Sickle cell disease includes a group of inherited 
disorders of haemoglobin production. Haemoglobin S 
polymerises when deoxygenated, causing rigidity of the 
erythrocytes, blood hyperviscosity and occlusion of the 
microcirculation with resultant tissue ischaemia and 
infarction. Literature has ascertained that haemoglobin 
polymerization which leads to erythrocyte rigidity and 
vaso-occlusion is central to the pathophysiology of SCD. 
Equally established is the importance of chronic 
anaemia, haemolysis and vasculopathy. Clinical 
management is basic and few treatments have a robust 
evidence base. This paper provides a solution to SCD 
pain management during VOC. Painful episodes can 
easily be managed by the healthcare sectors to serve as a 
great relief. The development of this framework would 
help solve some of the challenges that are faced in the 
healthcare system in SCD-related pain management. 
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